Why is Marksans Pharma falling/rising?

As of 28-Aug, Marksans Pharma Ltd is experiencing a decline in its stock price, currently at Rs 170.15, which reflects a decrease of Rs 3.05 or 1.76%. The stock has been underperforming, having fallen consecutively for the last six days, resulting in a total decline of 7.75% during this period. It is also trading close to its 52-week low, just 1.23% above Rs 168.05. In the past week, the stock has dropped by 6.02%, and over the last month, it has seen a significant decline of 24.86%. Despite a fair valuation indicated by a Price to Book Value of 3.1 and a high return on equity (ROE) of 17.66%, the company has reported negative results recently, with a substantial drop in profit before tax and profit after tax compared to previous quarters, contributing to the stock's downward trend.
In the broader market context, Marksans Pharma's performance has been notably worse than the benchmark, with a one-year return of -29.13% compared to the BSE500's -5.01%. This stark contrast highlights the company's struggles, particularly in light of its poor long-term growth, as evidenced by a negative annual growth rate in operating profit over the last five years. Although there has been a rise in investor participation, as indicated by increased delivery volume, the overall sentiment remains negative due to the company's recent financial performance and its inability to keep pace with market benchmarks.